Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia.
Blanche
P
P
Bouscary
D
D
Gombert
B
B
Stieltjes
N
N
Dreyfus
F
F
Sicard
D
D
D000368:Aged; D000906:Antibodies / Q000276:immunology*; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005169:Factor VIII / Q000009:adverse effects* / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000906:Antibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D005169:Factor VIII; D014740:Vidarabine; C024352:fludarabine